文献速递儿童感染儿童呼吸

儿科重症监护病房鲍曼不动杆菌耐药性分析

[Drug resistance of Acinetobacter baumannii in pediatric intensive care unit].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2021-01-01

该研究回顾性分析2014年1月至2018年12月中国医科大学附属盛京医院PICU患儿临床分离的311株鲍曼不动杆菌,发现CRAB占82.6%、MDRAB占65.9%,菌株对替加环素、阿米卡星、头孢哌酮舒巴坦敏感度较高。碳青霉烯类使用和介入性操作是CRAB产生的独立危险因素,CRAB中OXA-23、OXA-51及外排泵相关基因表达率显著高于非CRAB。

要点

  • PICU分离鲍曼不动杆菌中CRAB占82.6%、MDRAB占65.9%。
  • 菌株对替加环素(90.0%)、阿米卡星(80.4%)、头孢哌酮舒巴坦(62.1%)敏感度较高。
  • 碳青霉烯类使用(OR=3.179)和介入性操作(OR=5.107)是CRAB独立危险因素。

核心结论

  • PICU临床检出鲍曼不动杆菌中CRAB和MDRAB所占比例高,仅对替加环素、阿米卡星、头孢哌酮舒巴坦敏感度较高。
  • 碳青霉烯类抗菌药物暴露及介入性操作是CRAB菌株产生的独立危险因素。
  • 与非CRAB相比,CRAB存在高表达β-内酰胺酶相关基因OXA-23和OXA-51及外排泵相关基因AdeABC和AdeFGH。

研究设计与样本

  • 回顾性分析2014年1月至2018年12月中国医科大学附属盛京医院PICU患儿临床分离的311株鲍曼不动杆菌。
  • 根据耐药检测结果分为耐碳青霉烯鲍曼不动杆菌(CRAB)组和非CRAB组,采用t检验、Mann-Whitney U检验、χ²检验或Fisher确切检验进行组间对照分析,多元Logistic回归进行多因素分析。
  • 选取与CRAB密切相关基因进行实时定量PCR检测。

主要发现

  • 311株菌株对应166例患儿(男101例、女65例),年龄范围1月龄至14岁;常见原发病为重症支气管肺炎66例(39.8%)、中枢神经系统感染28例(16.9%)、外伤17例(10.2%)。
  • 311株菌株中82.6%(257/311)为CRAB,65.9%(205/311)为MDRAB。
  • AB对替加环素敏感度最高(280/311,90.0%),阿米卡星(250/311,80.4%)及头孢哌酮舒巴坦(193/311,62.1%)随后;多数AB对环丙沙星(247/311,79.4%)、氨苄西林(244/311,78.5%)和头孢他啶(245/311,78.8%)耐药。
  • CRAB组培养AB前碳青霉烯类药物使用率、三代头孢使用≥7 d、其他广谱抗菌药物使用率、联合使用抗菌药物率及介入性操作概率均高于非CRAB组(P=0.023、0.019、<0.01、0.008、0.003)。
  • IPM、OXA-24基因在CRAB和非CRAB中均有表达,差异均无统计学意义(均P>0.05);VIM及OXA-58基因在两组中未检测到;OXA-23、OXA-51及外排泵相关基因AdeABC和AdeFGH在CRAB中表达率均明显高于非CRAB(均P<0.01)。

关键数值与推荐

  • CRAB组培养AB前碳青霉烯类药物使用率26.2%(34/130)高于非CRAB组8.3%(3/36),χ²=5.169,P=0.023。
  • CRAB组三代头孢使用≥7 d比例43.8%(57/130)高于非CRAB组22.2%(8/36),χ²=5.533,P=0.019。
  • 多因素Logistic回归:培养AB前碳青霉烯类抗菌药物使用OR=3.179(95%CI 1.247~8.107,P=0.015),介入性操作OR=5.107(95%CI 1.446~18.042,P=0.011)。

临床怎么用

  • PICU中鲍曼不动杆菌感染经验性治疗需考虑CRAB和MDRAB高比例,替加环素、阿米卡星、头孢哌酮舒巴坦体外敏感度较高。
  • 应关注碳青霉烯类抗菌药物暴露及介入性操作患者发生CRAB的风险。
  • CRAB高表达OXA-23、OXA-51及外排泵相关基因,提示耐药机制涉及β-内酰胺酶和外排泵。

局限性

  • 本研究为单中心回顾性分析,样本来自中国医科大学附属盛京医院PICU。
  • 仅对部分CRAB相关基因进行检测,未覆盖所有可能耐药机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the drug resistance and related gene expression of Acinetobacter baumannii (AB) among the patients in pediatric intensive care unit (PICU). Methods: Drug resistance of 311 clinical cultured AB strains in PICU of Shengjing Hospital of China Medical University between January 2014 to December 2018 were analyzed retrospectively. According to the results of drug resistance test, all strains were divided into carbapenem-resistant Acinetobacter baumannii (CRAB) and non-carbapenem-resistant Acinetobacter baumannii (non-CRAB). The CRAB closely related genes were tested by real time quantitative polymerase chain reaction (RT-PCR). Comparison between the groups was analyzed by t test, Mann-Whitney U test, Chi-square test or Fisher exact test. Multivariate logistic regression was used for multivariate statistics. Results: A total of 166 patients with 311 AB strains were enrolled in this research, including 101 males and 65 females. The children's age ranged from 1 month to 14 years. The main primary diseases of 166 children were severe pneumonia (66/166, 39.8%), central nervous system infection (28/166, 16.9%), and trauma (17/166, 10.2%). Drug sensitivity tests showed that AB was sensitive to tigecycline (280/311, 90.0%), amikacin (250/311, 80.4%), and cefoperazone-sulbactam (193/311, 62.1%). However, most of AB strains were resistant to ciprofloxacin (247/311, 79.4%), ampicillin (244/311, 78.5%), and ceftazidime (245/311, 78.8%). In 311 isolated strains, 82.6% (257/311) strains were CRAB, and 65.9% (205/311) strains were multidrug-resistant Acinetobacter baumannii (MDRAB). Carbapenems were used more often in CRAB group than non-CRAB group before Acinetobacter baumannii cultured (26.2% (34/130) vs. 8.3% (3/36), χ²=5.169, P=0.023), and more patients in CRAB group used the third-generation cephalosporins for more than 7 days (43.8% (57/130) vs. 22.2% (8/36), χ²=5.533, P=0.019). Other broad-spectrum antibiotics or combined antibiotics in CRAB group were also more frequently used than in non-CRAB group (47.7% (62/130) vs. 13.9% (5/36), 46.9%(61/130) vs. 22.2%(8/36); χ²=13.383, 7.082; P<0.01, P=0.008). More patients in CRAB group received interventional procedures than those in non-CRAB group (75.4% (98/130) vs. 50.0% (18/36), χ²=8.631, P=0.003). Multivariate logistic regression showed that using carbapenem antibiotics (OR=3.179, 95%CI 1.247-8.107, P=0.015) and interventional procedures (OR=5.107, 95%CI 1.446-18.042, P=0.011) were independent risk factors for causing CRAB. Both IPM and OXA-24 genes had high expressions in CRAB and non-CRAB groups (89.2% (116/130) vs. 86.1% (31/36), P=0.565; 77.7% (101/130) vs. 72.2% (26/36), P=0.49). VIM and OXA-58 genes were not detected in any group. The expression rates of OXA-23, OXA-51, and efflux pump-related genes AdeABC and AdeFGH in CRAB group were significantly higher than in non-CRAB group (all P<0.01). Conclusions: In PICU, the proportions of CRAB and MDRAB were high and most of AB strains are only sensitive to tigecycline, amikacin, cefoperazone or sulbactam. Using carbapenems and interventional operation are independent risk factors for causing CRAB. Compared with non-CRAB, CRAB had higher expression of β-lactamase-related genes OXA-23 and OXA-51, and efflux pump-related genes AdeABC and AdeFGH. 目的: 了解儿科重症监护病房(PICU)鲍曼不动杆菌(AB)的耐药状况及耐药基因表达。 方法: 回顾性分析2014年1月至2018年12月中国医科大学附属盛京医院PICU患儿临床分离的311株菌株耐药性,根据耐药检测结果分为耐碳青霉烯鲍曼不动杆菌(CRAB)组和非CRAB组;选取与CRAB密切相关基因进行实时定量(RT)-PCR检测,采用t检验、MannWhitney U检验、χ²检验或Fisher确切检验进行组间对照分析。多元Logistic回归分析进行多因素分析。 结果: 311株菌株对应166例患儿(男101例、女65例),年龄范围为1月龄至14岁。重症支气管肺炎[66例(39.8%)]、中枢神经系统感染[28例(16.9%)]、外伤 [17例(10.2%)]是常见的原发病。药物敏感性试验分析提示,AB对替加环素敏感度最高(280/311,90.0%),阿米卡星(250/311,80.4%)及头孢哌酮舒巴坦(193/311,62.1%)随后。但多数AB对环丙沙星(247/311,79.4%)、氨苄西林(244/311,78.5%)和头孢他啶(245/311,78.8%)具有耐药性。311株菌株中有82.6%(257/311)为CRAB,65.9%(205/311)为多重耐药鲍曼不动杆菌(MDRAB)。CRAB组培养AB前碳青霉烯类药物使用率、三代头孢使用≥7 d、其他广谱抗菌药物使用率、联合使用抗菌药物率及介入性操作概率均高于非CRAB组[26.2%(34/130) 比8.3%(3/36)、43.8%(57/130)比22.2%(8/36)、47.7%(62/130)比13.9%(5/36)、46.9%(61/130)比 22.2%(8/36)、75.4%(98/130)比50.0%(18/36),χ²=5.169、5.533、13.383、7.082、8.631,P=0.023、0.019、<0.01、0.008、0.003];多因素Logistic回归分析提示培养AB前碳青霉烯类抗菌药物使用(OR=3.179,95%CI 1.247~8.107,P=0.015)和介入性操作(OR=5.107,95%CI 1.446~18.042,P=0.011)为CRAB产生的独立危险因素。IPM、OXA-24基因在CRAB和非CRAB 中均有表达,差异均无统计学意义[89.2%(116/130)和86.1%(31/36)、77.7%(101/130)和72.2%(26/36),均P>0.05];而VIM及OXA-58基因在两组中未检测到。β-内酰胺酶相关基因OXA-23、OXA-51及外排泵相关基因AdeA、B、C、F、G、H在CRAB中表达率均明显高于非CRAB(均P<0.01)。 结论: 在PICU临床总检出AB中,CRAB和MDRAB所占比例高;仅对替加环素、阿米卡星、头孢哌酮舒巴坦敏感度较高。碳青霉烯类抗菌药物暴露及介入性操作是CRAB菌株产生的独立危险因素。与非CRAB相比CRAB存在高表达β-内酰胺酶相关基因OXA-23和OXA-51及外排泵相关基因AdeA、B、C、F、G、H。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xu CF, Xu W. [Drug resistance of Acinetobacter baumannii in pediatric intensive care unit]. Zhonghua Er Ke Za Zhi. 2021. PMID: 34333917. doi:10.3760/cma.j.cn112140-20210117-00053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。